Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3343)
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
847
Price
$365.42
Total Value
$309.51K
Shares Held After
1,347,948
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
1,358
Price
$364.48
Total Value
$494.96K
Shares Held After
1,348,795
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
573
Price
$363.34
Total Value
$208.20K
Shares Held After
1,350,153
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,010
Price
$362.65
Total Value
$728.93K
Shares Held After
1,350,726
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
1,214
Price
$361.61
Total Value
$438.99K
Shares Held After
1,352,736
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,266
Price
$360.46
Total Value
$816.81K
Shares Held After
1,353,950
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,357
Price
$359.39
Total Value
$1.21M
Shares Held After
1,356,216
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,143
Price
$358.42
Total Value
$1.13M
Shares Held After
1,359,573
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,981
Price
$357.57
Total Value
$1.42M
Shares Held After
1,362,716
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
3,297
Price
$356.37
Total Value
$1.17M
Shares Held After
1,366,697
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
2,029
Price
$355.57
Total Value
$721.46K
Shares Held After
1,369,994
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
520
Price
$354.54
Total Value
$184.36K
Shares Held After
1,372,023
% of Holdings
0.0%
Atara Biotherapeutics, Inc. (ATRA)
Cherry Brian N — Director
Shares
104,166
Price
$9.60
Total Value
$999.99K
Shares Held After
166,486
% of Holdings
62.6%
Kymera Therapeutics, Inc. (KYMR)
Adams Brian — Chief Legal Officer
Shares
2,137
Price
$117.57
Total Value
$251.25K
Shares Held After
50,254
% of Holdings
4.1%
Kymera Therapeutics, Inc. (KYMR)
Adams Brian — Chief Legal Officer
Shares
3,025
Price
$116.81
Total Value
$353.35K
Shares Held After
52,391
% of Holdings
5.5%
Kymera Therapeutics, Inc. (KYMR)
Adams Brian — Chief Legal Officer
Shares
1,209
Price
$115.55
Total Value
$139.70K
Shares Held After
55,416
% of Holdings
2.1%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
3,625
Price
$2.51
Total Value
$9.09K
Shares Held After
106,015
% of Holdings
3.3%
Caris Life Sciences, Inc. (CAI)
Spetzler David Baxley — President
Shares
119,212
Price
$24.76
Total Value
$2.95M
Shares Held After
1,182,871
% of Holdings
9.2%
CYBIN INC. (CYBN)
Glavine Paul — Chief Growth Officer
Shares
100,000
Price
$11.78
Total Value
$1.18M
Shares Held After
4,171,252
% of Holdings
2.4%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
3,223
Price
$6.07
Total Value
$19.56K
Shares Held After
630,644
% of Holdings
0.5%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
2,877
Price
$6.07
Total Value
$17.46K
Shares Held After
562,715
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
400
Price
$288.98
Total Value
$115.59K
Shares Held After
36,514
% of Holdings
1.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
385
Price
$287.53
Total Value
$110.70K
Shares Held After
36,914
% of Holdings
1.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
2,115
Price
$286.36
Total Value
$605.65K
Shares Held After
37,299
% of Holdings
5.4%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
1,800
Price
$285.17
Total Value
$513.30K
Shares Held After
39,414
% of Holdings
4.4%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
300
Price
$283.99
Total Value
$85.20K
Shares Held After
41,214
% of Holdings
0.7%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
900,000
Price
$1.78
Total Value
$1.60M
Shares Held After
6,524,151
% of Holdings
13.8%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
45,000
Price
$102.85
Total Value
$4.63M
Shares Held After
813,209
% of Holdings
5.2%
Opus Genetics, Inc. (IRD)
Gagnon Robert E. — Chief Financial Officer
Shares
28,000
Price
$4.54
Total Value
$127.21K
Shares Held After
556,375
% of Holdings
4.8%
Ultragenyx Pharmaceutical Inc. (RARE)
Huizenga Theodore Alan — SVP, Chief Accounting Officer
Shares
161
Price
$13.99
Total Value
$2.25K
Shares Held After
69,146
% of Holdings
0.2%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
10,000
Price
$4.79
Total Value
$47.90K
Shares Held After
1,070,746
% of Holdings
0.9%
Definium Therapeutics, Inc. (DFTX)
Barrow Robert — Director
Shares
19,023
Price
$37.94
Total Value
$721.73K
Shares Held After
1,494,640
% of Holdings
1.3%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
800
Price
$1.09
Total Value
$872.00
Shares Held After
381,985
% of Holdings
0.2%
Alector, Inc. (ALEC)
Rosenthal Arnon — Director
Shares
72,606
Price
$2.66
Total Value
$193.47K
Shares Held After
2,294,600
% of Holdings
3.1%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
5,165
Price
$2.67
Total Value
$13.77K
Shares Held After
109,640
% of Holdings
4.5%
Alector, Inc. (ALEC)
Berkley Neil Lindsay — CFO&Chief Business Officer
Shares
29,251
Price
$2.66
Total Value
$77.95K
Shares Held After
350,649
% of Holdings
7.7%
Caris Life Sciences, Inc. (CAI)
Spetzler David Baxley — President
Shares
84,900
Price
$25.32
Total Value
$2.15M
Shares Held After
1,052,083
% of Holdings
7.5%
Caris Life Sciences, Inc. (CAI)
Spetzler David Baxley — President
Shares
393,100
Price
$24.76
Total Value
$9.73M
Shares Held After
1,136,983
% of Holdings
25.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
42
Price
$491.25
Total Value
$20.63K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
940
Price
$490.50
Total Value
$461.07K
Shares Held After
324,485
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,114
Price
$489.62
Total Value
$1.52M
Shares Held After
325,425
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,604
Price
$488.68
Total Value
$783.85K
Shares Held After
328,539
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,429
Price
$487.87
Total Value
$697.16K
Shares Held After
330,143
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
411
Price
$486.72
Total Value
$200.04K
Shares Held After
331,572
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$485.16
Total Value
$116.44K
Shares Held After
331,983
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$483.69
Total Value
$38.70K
Shares Held After
332,223
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$482.35
Total Value
$192.94K
Shares Held After
332,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$481.47
Total Value
$288.88K
Shares Held After
332,703
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$480.53
Total Value
$211.43K
Shares Held After
333,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$479.07
Total Value
$95.81K
Shares Held After
333,743
% of Holdings
0.1%
Showing 401–450 of 3343 transactions (page 9 of 67)